Investing in Japan
Latest UpdatesJapanese corporation of major US CRO PRA Health Sciences expands head office in Osaka
Apr 09, 2019
PRA Health Sciences, Inc., a leading US contract research organization (CRO) with approximately 80 bases in the world, is expanding the Osaka head office of its Japanese corporation in June 2019 to further develop business in the country.
The role of CROs has been increasing in recent years in Japan as well as in Europe and the United States. PRA Health Sciences entered a comprehensive partnership contract in clinical development with Takeda Pharmaceutical Co., Ltd. in August 2016 to develop full-fledged business in Japan. Later on, the company created its first Japanese company, PRA Health Sciences Corporation, in Osaka City in June 2017. At the same time, it set up Takeda PRA Development Center Co., Ltd., a joint venture company, with Takeda Pharmaceutical Co., Ltd..
After transferring the headquarters of its Japanese subsidiary to a larger office in Osaka in next June, the company aims to build a highly flexible and new kind of clinical trial implementation system in Japan through integrating the international base of its group and Japan’s expertise in pharmaceutical development.
To assist with the expanding of the company’s base in Japan, the JETRO Invest Japan Business Support Center (IBSC) Osaka provided information on incentive programs. The IBSC also referred a local real estate company and local government officials.